Buy Rapact : Everolimus 10 Mg Tablets Online

Description

1. Active Substance:
   • Rapact contains the active ingredient everolimus, which is a mammalian target of rapamycin (mTOR) inhibitor. Everolimus is used in the treatment of various types of cancer, including advanced breast cancer, advanced renal cell carcinoma (RCC), neuroendocrine tumors (NETs), and subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC).
2. Medical Uses:
   • Treatment of Cancer: Rapact is indicated for the treatment of cancer in several settings, including:
     • Advanced Breast Cancer: Rapact, in combination with exemestane, is used for the treatment of hormone receptor-positive, HER2-negative advanced breast cancer in postmenopausal women who have not responded to other therapies.
     • Advanced Renal Cell Carcinoma: Rapact is used for the treatment of advanced renal cell carcinoma (RCC) after failure of treatment with other agents.
     • Neuroendocrine Tumors: Rapact is used for the treatment of progressive, well-differentiated, nonfunctional neuroendocrine tumors (NETs) of gastrointestinal or lung origin that are unresectable, locally advanced, or metastatic.
     • Subependymal Giant Cell Astrocytoma: Rapact is used for the treatment of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC) in patients who require therapeutic intervention but are not candidates for curative surgical resection.
3. Mode of Action:
   • Everolimus inhibits the activity of the mammalian target of rapamycin (mTOR) kinase, which plays a key role in regulating cell growth, proliferation, and survival. By blocking mTOR signaling pathways, everolimus interferes with tumor cell growth and angiogenesis, leading to tumor regression and inhibition of disease progression.
4. Dosage and Administration:
   • Rapact is available as oral tablets containing 10 mg of everolimus. The dosage and administration schedule may vary depending on factors such as the type of cancer being treated, disease stage, patient’s weight, and overall health status.
   • It is typically taken orally, once daily, preferably at the same time each day, with or without food. The tablet should be swallowed whole with a glass of water, and it should not be crushed, chewed, or broken.
   • The recommended dosage may be adjusted based on individual response, tolerability, and treatment goals. Close monitoring of blood counts, liver function tests, and other relevant laboratory parameters is essential during treatment with everolimus.
5. Side Effects:
   • Common side effects of everolimus may include:
     • Fatigue or weakness
     • Stomatitis (mouth sores) or oral ulceration
     • Diarrhea
     • Rash or dermatitis
     • Anemia or decreased white blood cell count
     • Hyperglycemia (high blood sugar)
     • Hyperlipidemia (high cholesterol or triglycerides)
   • Serious side effects, such as infections, interstitial lung disease, renal toxicity, or delayed wound healing, may occur and require medical attention.
6. Precautions:
   • Before using Rapact, individuals should inform their healthcare provider about any existing medical conditions, especially liver or kidney disease, diabetes, or lung disorders.
   • Rapact should not be used in pregnant or breastfeeding women, as it may cause harm to the fetus or nursing infant. Effective contraception should be used during treatment and for at least eight weeks after discontinuation of everolimus.
   • Close monitoring of blood glucose levels, lipid levels, renal function, and signs of infection is essential during treatment with everolimus to detect and manage any potential adverse effects or complications.
7. Prescription Required:
   • Yes, Rapact is a prescription medication, and its use should be guided by a healthcare professional’s prescription.
8. Note:
   • Rapact is an important treatment option for patients with various types of cancer, offering the potential for disease control and improved outcomes.
   • It is essential for individuals prescribed Rapact to follow their healthcare provider’s instructions carefully, report any side effects or concerns promptly, and attend regular follow-up appointments for monitoring and assessment of treatment response.

Rapact represents a valuable addition to the armamentarium of treatments for advanced cancer, offering the potential for disease stabilization and improved quality of life for patients. It is important for individuals undergoing treatment with Rapact to receive comprehensive support and monitoring from their healthcare team to optimize treatment outcomes and minimize adverse effects.